...
首页> 外文期刊>Khyber Medical University Journal >ST ELEVATION MYOCARDIAL INFARCTION: AN EXPERIENCE AT LADY READING HOSPITAL PESHAWAR, PAKISTAN
【24h】

ST ELEVATION MYOCARDIAL INFARCTION: AN EXPERIENCE AT LADY READING HOSPITAL PESHAWAR, PAKISTAN

机译:急性心肌梗塞:巴基斯坦佩沙瓦医院女读书的经验

获取原文
           

摘要

ABSTRACTOBJECTIVE: To find out the clinical characteristics, treatment offered and outcome of patients with ST elevation myocardial infarction (STEMI) admitted to cardiology unit Lady Reading Hospital (LRH), Peshawar, Pakistan.METHODS: This retrospective observational study was conducted in Cardiology Unit, LRH, Peshawar, Pakistan by analyzing record of all diagnosed STEMI patients of age >18 years, from 1st January to 31 December 2013.RESULTS: Total number of patients admitted with STEMI were 1733 (46.02% of total coronary artery disease admission). Of all these patients with STEMI, fibrinolytic therapy with streptokinase were given to 1380 (79.6%) patients, while 343 (19.8%) were late for fibrinolytic therapy or having some contraindication to fibrinolytic therapy. Ninety four (5.4%) patients received primary or rescue percutaneous coronary intervention (PCI). Out of 1733 patients, males were 1085 (62.60%), female were 648 (37.40%), mean age was 57.42±8.7 years, diabetes was found in 458 (26.39%) cases, hypertension in 679 (39.18%) cases, smokers were 183 (10.5%). Family history of coronary artery disease (CAD) was found in 205 (11.82%) cases, past history for CAD was present in 305 (17.5%) patients and anterior wall myocardial Infarction & new onset left bundle branch block was found in 790 (45%) cases. In-hospital mortality was 158 (9.1%).CONCLUSION: About 46% of patients admitted with CAD were having STEMI, of them 80% receive streptokinase while only 5.4% were subjected to primary or rescue PCI. In-hospital mortality is about 9%. Anterior wall MI was the most frequent AMI.KEY WORDS: Coronary Artery Disease (MeSH), Streptokinase (MeSH), Myocardial Infarction (MeSH), Percutaneous Coronary Intervention (MeSH), Hospital Mortality (MeSH), Thrombolytic Therapy (MeSH).
机译:摘要:为了了解巴基斯坦白沙瓦夫人医院雷丁医院(LRH)收治的ST段抬高型心肌梗死(STEMI)患者的临床特征,提供的治疗方法和结局。通过分析2013年1月1日至12月31日所有确诊的年龄大于18岁的STEMI患者的记录,分析了巴基斯坦的Peshawar的结果。结果:STEMI的总患者为1733名(占总冠状动脉疾病的46.02%)。在所有这些STEMI患者中,有1380名(79.6%)患者接受了链激酶的纤溶治疗,而343名(19.8%)的纤溶治疗迟到或有纤溶治疗的禁忌症。 94名(5.4%)患者接受了原发性或抢救性经皮冠状动脉介入治疗(PCI)。在1733名患者中,男性为1085(62.60%),女性为648(37.40%),平均年龄为57.42±8.7岁,糖尿病为458(26.39%),高血压为679(39.18%),吸烟者是183(10.5%)。 205例(11.82%)患儿有冠状动脉疾病家族史(CAD),305例(17.5%)患儿有CAD既往史,790例有前壁心肌梗塞和新发左束支传导阻滞(45) %)个案例。结论:院内死亡率为158(9.1%)。结论:约46%的CAD患者患有STEMI,其中80%接受链激酶治疗,而只有5.4%接受原发性或抢救性PCI。院内死亡率约为9%。前壁MI是最常见的AMI。关键词:冠状动脉疾病(MeSH),链激酶(MeSH),心肌梗死(MeSH),经皮冠状动脉介入治疗(MeSH),医院死亡率(MeSH),溶栓治疗(MeSH)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号